In vivo proton magnetic resonance spectroscopy for metabolic changes in brain during chronic cerebral vasospasm in primates

Neurosurgery

Volumn 40, Issue 4, 1997, Pages 773-781

  Handa, Yuji ^a   Kaneko, Masanori ^a   Matuda, Tuyoshi ^a   Kobayashi, Hidenori ^a   Kubota, Toshihiko ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Cerebral vasospasm; Primate; Proton magnetic resonance spectroscopy; Subarachnoid hemorrhage

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ANIMAL MODEL; ARTICLE; BRAIN SURGERY; BRAIN VASOSPASM; CONTROLLED STUDY; FEMALE; MACACA; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SUBARACHNOID HEMORRHAGE;

ANIMALS; ASPARTIC ACID; BRAIN; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; CHOLINE; CHRONIC DISEASE; COGNITION DISORDERS; CREATININE; ENERGY METABOLISM; FEMALE; ISCHEMIC ATTACK, TRANSIENT; MACACA FASCICULARIS; MAGNETIC RESONANCE IMAGING; NEURONS; PHOSPHOCREATINE; SUBARACHNOID HEMORRHAGE;

EID: 0030937037     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199704000-00023     Document Type: Article

References (33)

1. Birken DL, Olderdorf WH: N-Acetyl-L-aspartic acid: A literature review of a compound prominent in 'H-spectroscopic studies of the brain. Neurosci Biobehav Rev 13:23-31, 1989.
2. Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hänicke W, Sauter R: Cerebral metabolism in man after acute stroke: New observation using localized proton NMR spectroscopy. Magn Reson Med 9:126-131,1989.
3. Fortuny LA, Prieto-Valiente LR: Long-term prognosis in surgically treated intracranial aneurysm: Part 2-Morbidity. J Neurosurg 54:35-43, 1981.
4. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R: Localized proton NMR spectroscopy in different regions of the human brain in vivo: Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 11:47-63,1989.
5. Gill SS, Thomas DGT, von Bruggen N, Gadian DG, Feden CJ, Bell JD, Cox IJ, Menon DK, lies RA, Bryant DJ, Coutts GA: Proton MR spectroscopy of intracranial tumours: In vivo and in vitro studies. J Comput Assist Tomogr 14:497-504, 1990.
6. Graham GD, Blamire AM, Howseman AM, Rothman DL, Fayad PB, Brass LM, Petroff OAC, Shulman RG, Prichard JW: Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 23:333-340, 1992.
7. Handa Y, Hayashi M, Takeuchi H, Kubota T, Kobayashi H, Kawano H: Time course of the impairment of cerebral autoregulation during chronic cerebral vasospasm after subarachnoid hemorrhage in primates. J Neurosurg 76:493-501,1992.
8. Handa Y, Kubota T, Tsuchida A, Kaneko M, Cancr H, Kobayashi H, Kubota T: Effect of systemic hypotension on cerebral energy metabolism during chronic cerebral vasospasm in primates. J Neurosurg 78:112-119,1993.
9. Houkin K, Kamada K, Kamiyama H, Iwasaki Y, Abe H, Kashiwaba T: Longitudinal changes in proton magnetic resonance spectroscopy in cerebral infarction. Stroke 24:1316-1321,1993.
10. Howe FA, Maxwell RJ, Saunders DE, Brown MM, Griffiths JR: Proton spectroscopy in vivo. Magn Reson Q 9:31-39, 1993.
11. Le Roux PD, Elliott JP, Downey L, Newell DW, Grady MS, Mayberg MR, Eskbridge JM, Winn HR: Improved outcome after rupture of anterior circulation aneurysms: A retrospective 10-year review of 224 good-grade patients. J Neurosurg 83:394402, 1995.
12. Lewis LD, Ljunggren B, Ratcheson RA, Siesjö BK: Cerebral energy state in insulin-induced hypoglycemia, related to blood glucose and to EEC. J Neurochem 23:673-679,1974.
13. Ljunggren B, Sonesson B, Säveland H, Brandt L: Cognitive impairment and adjustment in patients without neurological deficits after aneurysmal SAH and early operation. J Neurosurg 62:673679,1985.
14. Matthews PM, Francis G, Antel J, Arnold DL: Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 41:1251-1256,1991.
15. Menon DK, Baudouin CJ, Tomlinson D, Hoyel C: Proton MR spectroscopy and imaging of the brain in AIDS: Evidence of neuronal loss in regions that appear normal with imaging. J Cornput Assist Tomogr 14:882-885, 1990.
16. Menon DK, Sargentoni J, Peden CJ, Bell JD, Cox IJ, Coutts GA, Baudouin C, Newman CG: Proton MR spectroscopy in herpes simplex encephalitis: Assessment of neuronal loss. J Comput Assist Tomogr 14:449-452,1990.
17. Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, Fein G: Reduced N-acetyl-aspartate suggests neuronal loss in cognitively impaired human immunodeficiency virusséropositive individuals: In vivo aH magnetic resonance spectroscopic imaging. Neurology 43:509-515,1993.
18. Monsein LH, Mathews VP, Barker PB, Pardo CA, Blackband SJ, Whitlow WD, Wong DF, Bryan RN: Irreversible regional cerebral ischemia: Serial MR imaging and proton spectroscopy in a nonhuman primate model. AJNR Am J Neuroradiol 14:963-970, 1993.
19. Nadler JV, Cooper JR: N-Acetyl-L-aspartic acid content of human neural tumors and bovine peripheral nerve tissues. J Neurochem 19:313-319, 1972.
20. Neil-Dwyer G, Lang DA, Doshi B, Gerber CJ, Smith PWF: Delayed cerebral ischemia: The pathological substrate. Acta Neurochir (Wien) 131:137-145,1994.
21. Petroff OAC, Ogino T, Alger JR: High-resolution proton magnetic resonance spectroscopy of the brain: Regional metabolite levels and postmortem changes. J Neurochem 51:163-171,1988.
22. Richardson JT: Performance in free recall following rupture and repair of intracranial aneurysm. Brain Cogn 9:210-226, 1989.
23. Romner B, Sonesson B, Ljunggren B, Brandt L, Säveland H, Holtâs S: Late magnetic resonance imaging related to neurobehavioral functioning after subarachnoid hemorrhage. Neurosurgery 25: 390-397, 1989.
24. Ropper AH, Zervas NT: Outcome 1 year after SAH from cerebral aneurysm: Management morbidity, mortality, and functional status in 112 consecutive good-risk patients. J Neurosurg 60:909-915, 1984.
25. Sager TN, Laursen H, Hansen AJ: Changes in N-acetyl-aspartate content during focal and global brain ischemia of the rat. J Cereb Blood Flow Metab 15:639-646,1995.
26. Sappey-Marinier D, Calabrese G, Hetherington HP, Fisher SNG, Deicken R, van Dyke C, Fein G, VVeiner MVV1: Proton magnetic resonance spectroscopy of human brain: Applications to normal white matter, chronic infarction, and MRI \vhite matter signal hyperintensities. Magn Reson Med 26:313-327, 1992.
27. Säveland H, Hillman J, Brand L, Edner G, Jokobsson KE, Algers G: Overall outcome in aneurysmal subarachnoid hemorrhage: A retrospective study from neurosurgical units in Sweden during a 1-year period. J Neurosurg 76:729-734, 1992.
28. Scremin OU, Jenden DJ: Focal ischemia enhances choline output and decreases acetylcholine output from rat cerebral cortex. Stroke 20:92-95,1989.
29. Segebarth CM, Balériaux DF, Luyten PR, den Hollander JA: Detection of metabolic heterogeneity of human intracranial tumors in vivo by ]H NMR spectroscopic imaging. Magn Reson Med 13:62-76, 1990.
30. Sonesson B, Ljunggren B, Säveland H, Brandt L: Cognition and adjustment after late and early operation for ruptured aneurysm. Neurosurgery 21:279-287, 1987.
31. Takeuchi H, Handa Y, Kobayashi H, Kawano H, Hayashi M: Impairment of cerebral autoregulation of chronic cerebral vasospasm after subarachnoid hemorrhage in primates. Neurosurgery 28:41-48, 1991.
32. Talen H, Moore S, Stein WH: N-Acetyl-aspartic acid in brain. J Biol Chem 219:256-264,1959.
33. Wieloch T: Neurochemical correlates to selective neuronal vulnerability. Prog Brain Res 63:69-85, 1985.